Determination of PHYLLANTHIN (cas 10351-88-9) and Gallic Acid In Herbal Hepatoprotective Formulation By TLC-Densitometry Analysis
-
Add time:08/04/2019 Source:sciencedirect.com
Introduction: Phyllanthus niruri, Andrographis paniculata and Embilica officinalis are most important and high value medicinal plant known for its hepatoprotective activity. Several analytical methods including HPTLC and HPLC are reported for respective phytoconstituents. However, there is no simultaneous estimation of PHYLLANTHIN (cas 10351-88-9) and gallic acid reported. The Objective of present work is to develop and validate HPtlc method for simultaneous determination of phyllanthin and gallic acid in polyherbal hepatoprotective formulation. Method: The method is employed tlc alumina plates precoated with silica gel 60F-254 as a stationary phase and toluene: ethyl acetate: formic acid (5:3.5:0.5 v/v/v) as a mobile phase. The standard markers namely phyllanthin and galic acid were identified in polyherbal formulation containing P.niruri and E.officinalis by Rf value. Densitometric analysis of phyllanthin and gallic acid was carried out at 254nm. Results: The precision of method was confirmed by relative standard deviation (RSD) which was lower than the 2%. This method was found to give proper separation of phyllanthin and gallic acid. The linear regression data for calibration plot shown good relationship with r2=0.998 (phyllanthin) and 0.9991(gallic acid) in the concentration range 5-9 µg/band. The method was validated for precision, accuracy, sensitivity, and specificity. Conclusion: statistical analysis proves that method is accurate and reproducible. The method is economical and can be employed for routine analysis of marketed polyherbal hepatoprotective formulation containing P.niruri and E.officinalis.
We also recommend Trading Suppliers and Manufacturers of PHYLLANTHIN (cas 10351-88-9). Pls Click Website Link as below: cas 10351-88-9 suppliers
Prev:Endothelium-independent effects of PHYLLANTHIN (cas 10351-88-9) and hypoPHYLLANTHIN (cas 10351-88-9) on vascular tension
Next:Immobilization mediated enhancement of PHYLLANTHIN (cas 10351-88-9) and hypoPHYLLANTHIN (cas 10351-88-9) from Phyllanthus amarus) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Investigation of anticancer potential of hypoPHYLLANTHIN (cas 10351-88-9) and PHYLLANTHIN (cas 10351-88-9) against breast cancer by in vitro and in vivo methods08/06/2019
- Immobilization mediated enhancement of PHYLLANTHIN (cas 10351-88-9) and hypoPHYLLANTHIN (cas 10351-88-9) from Phyllanthus amarus08/05/2019
- Endothelium-independent effects of PHYLLANTHIN (cas 10351-88-9) and hypoPHYLLANTHIN (cas 10351-88-9) on vascular tension08/03/2019
- Cytotoxic, caspase-3 induction and in vivo hepatoprotective effects of PHYLLANTHIN (cas 10351-88-9), a major constituent of Phyllanthus niruri08/02/2019
- Ameliorative effects of PHYLLANTHIN (cas 10351-88-9) on carbon tetrachloride-induced hepatic oxidative damage in mice08/01/2019
- PHYLLANTHIN (cas 10351-88-9) from Phyllanthus amarus inhibits cellular and humoral immune responses in Balb/C mice07/31/2019
- HPLC fingerprint and simultaneous quantitative analysis of PHYLLANTHIN (cas 10351-88-9) and hypoPHYLLANTHIN (cas 10351-88-9) for identification and authentication of Phyllanthus niruri from related species07/30/2019
- Antimicrobial activity of Phyllanthus amarus Schumach. & Thonn and inhibition of the NorA efflux pump of Staphylococcus aureus by PHYLLANTHIN (cas 10351-88-9)07/29/2019
- Preparation, toxicity analysis and in vivo protective effect of PHYLLANTHIN (cas 10351-88-9)-loaded PLGA nanoparticles against CCl4-induced hepatic fibrosis07/28/2019


